Sirdás sisdollui
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Giella
Buot deaivamat
Bajilčálus
Dahkki
Fáddá
Hildobáiki
ISBN/ISSN
Fáddágilkor
Viečča
Aiddostahtton
The value of bone turnover mar...
Čujuhandieđut
Deakstadieđáhus
Sádde šleađgaboasttain
Čálit
Doalvvo čujuhusa
Doalvun: RefWorks
Doalvun: EndNoteWeb
Doalvun: EndNote
Bissovaš liŋka
The value of bone turnover markers in the prediction of vertebral fracture in patients using oral glucocorticoids.
Čájet eará veršuvnnaid (1)
Bibliográfalaš dieđut
Váldodahkkit:
van Staa, T
,
Eastell, R
,
Barton, I
,
Rizzoli, R
,
Javaid, M
,
Cooper, C
Materiálatiipa:
Conference item
Almmustuhtton:
2003
Oažžasuvvandieđut
Govvádus
Eará veršuvnnat (1)
Geahča maid
Bargiidšearbma
Geahča maid
The value of bone turnover markers in the prediction of vertebral fracture in patients using oral glucocorticoids.
Dahkki: van Staal, T, et al.
Almmustuhtton: (2003)
PREDICTORS FOR VERTEBRAL FRACTURES AND FRACTURE THRESHOLD IN PATIENTS USING ORAL GLUCOCORTICOIDS
Dahkki: van Staa, T, et al.
Almmustuhtton: (2003)
Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy.
Dahkki: Van Staa, T, et al.
Almmustuhtton: (2003)
Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate
Dahkki: Watts, N, et al.
Almmustuhtton: (2004)
Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate: greater increases in bone mineral density do not relate to greater decreases in fracture risk.
Dahkki: Watts, N, et al.
Almmustuhtton: (2004)